During the past decade, Medical Radiological Research Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 14 clinical trials were completed, i.e. on average, 107.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Radiological Research Center" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Biocad" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Radiological Research Center" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Medical Radiological Research Center" are "Prostate Cancer" (4 trials), "Mantle Cell Lymphoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Medical Radiological Research Center" in a lesser frequency.

Most popular intervention types in "Medical Radiological Research Center" are "Drug" (28 trials), "Biological" (6 trials), "Other" (3 trials), "Radiation" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Gemcitabine" (4 trials), "Atezolizumab" (3 trials), "Carboplatin" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical Radiological Research Center" are 24 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Radiological Research Center". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Medical Radiological Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Radiological Research Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".